Search

Your search keyword '"ISARIC4C Investigators"' showing total 47 results

Search Constraints

Start Over You searched for: Author "ISARIC4C Investigators" Remove constraint Author: "ISARIC4C Investigators"
47 results on '"ISARIC4C Investigators"'

Search Results

1. Accelerated immune ageing is associated with COVID-19 disease severity

2. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

3. Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity

4. Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

5. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

6. The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020

7. SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study

8. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.

9. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

10. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.

11. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol : development and validation of the 4C Mortality Score

12. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom : prospective multicentre observational cohort study

13. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol : prospective observational cohort study

16. Adeno-associated virus 2 infection in children with non-A–E hepatitis

17. Adeno-associated virus 2 infection in children with non-A-E hepatitis

18. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

19. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

20. Adeno-associated virus 2 infection in children with non-A–E hepatitis

21. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

22. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study

23. Fewer COVID-19 neurological complications with dexamethasone and remdesivir

24. Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

25. The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020

26. Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients

27. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

28. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors : a cross-sectional study

29. A prenylated dsRNA sensor protects against severe COVID-19

30. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

31. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

32. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

33. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.

34. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study.

35. Genetic mechanisms of critical illness in COVID-19

36. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study

37. Outcome of hospitalisation for COVID-19 in patients with interstitial lung disease: an international multicentre study

38. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

39. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort.

40. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

41. Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

42. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study.

43. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

44. Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

45. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

47. Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Catalog

Books, media, physical & digital resources